Recent News

• 01.21.2026 - Paysign, Inc. to Present at the Oppenheimer 11th Annual Emerging Growth Conference
• 01.07.2026 - Paysign, Inc. Announces 2025 Performance Analysis of Patient Affordability Solutions
• 11.13.2025 - Paysign, Inc. to Present at the 17th Annual Southwest IDEAS Investor Conference
• 11.12.2025 - Paysign, Inc. Reports Third Quarter 2025 Financial Results
• 11.10.2025 - Paysign is Attending the Trade and Channel Strategies, Philadelphia, PA
• 10.22.2025 - Paysign is a Sponsor at the Patient Support Services Congress, East Brunswick, NJ
• 10.21.2025 - Paysign is a Sponsor and Speaker at the Copay, Reimbursement and Access Congress, East Brunswick, NJ
• 10.14.2025 - Paysign to Host Third Quarter 2025 Earnings Call
• 09.23.2025 - Paysign is a Sponsor at the 2025 PPTA Plasma Protein Forum, Alexandria, VA
• 09.22.2025 - Paysign, Inc. Appoints Jose Garcia as Executive Vice President, Life Science Solutions

Recent Filings

• 12.12.2025 - 4 Statement of changes in beneficial ownership of securities
• 11.13.2025 - 10-Q Quarterly report [Sections 13 or 15(d)]
• 11.12.2025 - 8-K Current report
• 09.26.2025 - 4 Statement of changes in beneficial ownership of securities
• 09.26.2025 - 4 Statement of changes in beneficial ownership of securities
• 09.26.2025 - 4 Statement of changes in beneficial ownership of securities
• 09.26.2025 - 4 Statement of changes in beneficial ownership of securities
• 09.26.2025 - 4 Statement of changes in beneficial ownership of securities
• 09.16.2025 - 8-K Current report
• 09.16.2025 - EX-99.1 EX-99.1